B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 720 KRW 1.51%
Market Cap: 481.3B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNote Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Net Income (Common)
-â‚©20.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Net Income (Common)
â‚©323.3B
CAGR 3-Years
-18%
CAGR 5-Years
6%
CAGR 10-Years
11%
SK Bioscience Co Ltd
KRX:302440
Net Income (Common)
â‚©22.3B
CAGR 3-Years
-12%
CAGR 5-Years
20%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Net Income (Common)
â‚©112B
CAGR 3-Years
20%
CAGR 5-Years
18%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Net Income (Common)
â‚©90.7B
CAGR 3-Years
30%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Net Income (Common)
-â‚©2.9B
CAGR 3-Years
51%
CAGR 5-Years
18%
CAGR 10-Years
N/A
No Stocks Found

BioNote Inc
Glance View

Market Cap
481.7B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
4 394.57 KRW
Overvaluation 7%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Net Income (Common)?
Net Income (Common)
-20.5B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Net Income (Common) amounts to -20.5B KRW.

Back to Top